In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Flurina Saner to discuss the Fagotti Score at interval surgery in ovarian cancer. Dr. Saner, gynecologist and obstetrician, is a gynae oncology fellow at the University Hospital Inselspital Bern, Switzerland. Her research focuses on patients with ovarian cancer and clinical and molecular determinants for long-term survival.

Highlights:

• The Fagotti score after neoadjuvant treatment shows a strong correlation with resection status, progression-free and overall survival of patients with advanced ovarian cancer
• ΔFagotti – indicating the change of the score during neoadjuvant chemotherapy - tracks with outcome after neoadjuvant chemotherapy for ovarian cancer
• Fagotti scores are valuable for an individualized patient treatment planning and should be routinely assessed at time of interval debulking surgery.
• The prognostic value of the Fagotti score after neoadjuvant therapy should be further validated in a prospective study, f.e. the LANCE trial.